{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:43:18Z","timestamp":1763142198437,"version":"build-2065373602"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["E-MTAB-11799"],"award-info":[{"award-number":["E-MTAB-11799"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007065","name":"University of Salerno","doi-asserted-by":"publisher","award":["300397FRB19CASOL","300397FRB21CASOL"],"award-info":[{"award-number":["300397FRB19CASOL","300397FRB21CASOL"]}],"id":[{"id":"10.13039\/501100007065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro Airc","doi-asserted-by":"publisher","award":["MFAG 11729"],"award-info":[{"award-number":["MFAG 11729"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jcyt.2023.11.014","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T18:36:28Z","timestamp":1702578988000},"page":"145-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell\u2013based vaccine efficiency to elicit antitumor immune response in vitro"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-2969","authenticated-orcid":false,"given":"Barbara","family":"Montico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annunziata","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-0520","authenticated-orcid":false,"given":"Maria Julia","family":"Lamberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Martorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"Mastorci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1003-2922","authenticated-orcid":false,"given":"Maria","family":"Ravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Giurato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6320-3054","authenticated-orcid":false,"given":"Agostino","family":"Steffan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-9853","authenticated-orcid":false,"given":"Riccardo","family":"Dolcetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9810-0488","authenticated-orcid":false,"given":"Vincenzo","family":"Casolaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0042-2161","authenticated-orcid":false,"given":"Jessica","family":"Dal Col","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.11.014_bib0001","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1387\/ijdb.150061pa","article-title":"Immunogenic cell death","volume":"59","author":"Garg","year":"2015","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0002","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.18632\/oncotarget.2266","article-title":"Immunogenic cell death inducers as anticancer agents","volume":"5","author":"Kepp","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0003","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jinorgbio.2016.06.021","article-title":"Anticancer metal drugs and immunogenic cell death","volume":"165","author":"Terenzi","year":"2016","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2018.08.028","article-title":"Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies","volume":"438","author":"Wang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0005","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0006","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41467-019-09415-3","article-title":"Crizotinib-induced immunogenic cell death in non\u2013small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0007","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081564","article-title":"An overview on immunogenic cell death in cancer biology and therapy","volume":"14","author":"Rodrigues","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0009","first-page":"53","article-title":"Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation","volume":"1805","author":"Garg","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0010","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s10495-010-0479-7","article-title":"Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity","volume":"15","author":"Garg","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0012","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/imr.12582","article-title":"Immunogenic stress and death of cancer cells: contribution of antigenicity vs adjuvanticity to immunosurveillance","volume":"280","author":"Bloy","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030256","article-title":"Dendritic cells and immunogenic cancer cell death: a combination for improving antitumor immunity","volume":"12","author":"Lamberti","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0014","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356964","article-title":"Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy","volume":"6","author":"Montico","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41435-021-00161-5","article-title":"Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma","volume":"23","author":"Decraene","year":"2022","journal-title":"Genes Immun"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0016","article-title":"Immunogenic cell death in hematological malignancy therapy","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"suppl_12","key":"10.1016\/j.jcyt.2023.11.014_bib0017","doi-asserted-by":"crossref","first-page":"xii44","DOI":"10.1093\/annonc\/mdx237","article-title":"Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy","volume":"28","author":"Sanchez-Paulete","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102424","article-title":"Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity","volume":"24","author":"Moriya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/cdd.2013.48","article-title":"Danger signalling during cancer cell death: origins, plasticity and regulation","volume":"21","author":"Garg","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.4078","article-title":"The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death","volume":"22","author":"Pozzi","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0021","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.3389\/fimmu.2019.02614","article-title":"Photodynamic modulation of type 1 interferon pathway on melanoma cells promotes dendritic cell activation","volume":"10","author":"Lamberti","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081896","article-title":"Integration of miRNA:mRNA co-expression revealed crucial mechanisms modulated in immunogenic cancer cell death","volume":"10","author":"Lamberti","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0023","doi-asserted-by":"crossref","first-page":"41913","DOI":"10.18632\/oncotarget.9630","article-title":"Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma","volume":"7","author":"Mastorci","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145617","article-title":"Phospholipid scramblase 1 modulates FcR-mediated phagocytosis in differentiated macrophages","volume":"11","author":"Herate","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12964-022-00895-3","article-title":"Phospholipid scramblase 1: a protein with multiple functions via multiple molecular interactors","volume":"20","author":"Dal Col","year":"2022","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0026","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1128\/JVI.78.17.8983-8993.2004","article-title":"Phospholipid scramblase 1 potentiates the antiviral activity of interferon","volume":"78","author":"Dong","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2012.01.010","article-title":"Inhibition of Hepatitis B virus replication by phospholipid scramblase 1 in vitro and in vivo","volume":"94","author":"Yang","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006851","article-title":"Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication","volume":"14","author":"Luo","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0029","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.chom.2011.12.004","article-title":"Phospholipid scramblase 1 mediates type i interferon-induced protection against staphylococcal alpha-toxin","volume":"11","author":"Lizak","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2006.01.018","article-title":"Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow","volume":"311","author":"George","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0031","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-11-2505","article-title":"Retinoic acid\/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets","volume":"72","author":"Dal Col","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0032","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4939-8885-3_22","article-title":"A novel dendritic cell-based vaccination protocol to stimulate immunosurveillance of aggressive cancers","volume":"1884","author":"Nigro","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0033","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.18632\/oncotarget.2476","article-title":"RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer","volume":"5","author":"Hashim","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0034","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0035","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0036","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0037","doi-asserted-by":"crossref","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","article-title":"VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots","volume":"10","author":"Goedhart","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0038","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0039","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1069938","article-title":"Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: a large-scale meta-analysis","volume":"5","author":"Garg","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41419-021-04178-6","article-title":"Immunogenic cell death and immunogenic surrender: related but distinct mechanisms of immune surveillance","volume":"12","author":"Mezzapelle","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0041","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41418-021-00853-5","article-title":"Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1alpha kinase inhibitor KIRA6 through HSP60 targeting","volume":"29","author":"Rufo","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0042","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","article-title":"InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams","volume":"16","author":"Heberle","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0043","first-page":"160","article-title":"ggplot2: Elegant Graphics for Data Analysis (2nd ed.)","volume":"17","author":"Villanueva","year":"2019","journal-title":"Measurement: Interdisciplinary Research and Perspectives"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0044","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0045","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/eji.200535579","article-title":"IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens","volume":"36","author":"Lapenta","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0046","doi-asserted-by":"crossref","first-page":"42707","DOI":"10.1074\/jbc.M506178200","article-title":"Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0047","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-12-32","article-title":"Phospholipid scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN\/SkiL in ovarian cancer cells","volume":"12","author":"Kodigepalli","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0048","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbrc.2015.11.131","article-title":"Two c-Myc binding sites are crucial in upregulating the expression of human phospholipid scramblase 1 gene","volume":"469","author":"Vinnakota","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0049","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/cr.2012.45","article-title":"Phospholipid scramblase 1 regulates Toll-like receptor 9\u2013mediated type I interferon production in plasmacytoid dendritic cells","volume":"22","author":"Talukder","year":"2012","journal-title":"Cell Res"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0050","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1523\/JNEUROSCI.3654-12.2013","article-title":"Phospholipid scramblase-1\u2013induced lipid reorganization regulates compensatory endocytosis in neuroendocrine cells","volume":"33","author":"Ory","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0051","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1021\/bi025610l","article-title":"Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor","volume":"41","author":"Sun","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0052","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fonc.2015.00007","article-title":"Mechanisms of translocation of ER chaperones to the cell surface and immunomodulatory roles in cancer and autoimmunity","volume":"5","author":"Wiersma","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0053","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1038\/s41467-018-06807-9","article-title":"Macrophages regulate the clearance of living cells by calreticulin","volume":"9","author":"Krysko","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0054","article-title":"CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma","volume":"6","author":"Lewinsky","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccell.2019.01.002","article-title":"Antitumor responses in the absence of toxicity in solid tumors by targeting B7-H3 via chimeric antigen receptor T cells","volume":"35","author":"Du","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0056","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1086862","article-title":"Tumor-intrinsic oncogene pathways mediating immune avoidance","volume":"5","author":"Spranger","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0057","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0058","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1386829","article-title":"Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0059","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0060","article-title":"Autocrine signaling of type 1 interferons in successful anticancer chemotherapy","volume":"4","author":"Vacchelli","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0061","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0062","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0063","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1182\/blood.V95.8.2593","article-title":"Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha","volume":"95","author":"Zhou","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0064","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.7150\/thno.43150","article-title":"Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0065","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1128\/MCB.26.9.3401-3413.2006","article-title":"The negative c-Myc target onzin affects proliferation and apoptosis via its obligate interaction with phospholipid scramblase 1","volume":"26","author":"Li","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0066","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbalip.2004.12.013","article-title":"The phospholipid scramblase PLSCR1 increases UV induced apoptosis primarily through the augmentation of the intrinsic apoptotic pathway and independent of direct phosphorylation by protein kinase C delta","volume":"1733","author":"Bailey","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0067","doi-asserted-by":"crossref","first-page":"23065","DOI":"10.1074\/jbc.M003116200","article-title":"Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta","volume":"275","author":"Frasch","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173815","article-title":"Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo","volume":"12","author":"Kassas-Guediri","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0069","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0161-5890(02)00069-X","article-title":"Phospholipid scramblase, a new effector of FcepsilonRI signaling in mast cells","volume":"38","author":"Pastorelli","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109800","article-title":"Regulation of the tyrosine phosphorylation of Phospholipid Scramblase 1 in mast cells that are stimulated through the high-affinity IgE receptor","volume":"9","author":"Kassas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2016.12.021","article-title":"Phosphatidylserine exposure controls viral innate immune responses by microglia","volume":"93","author":"Tufail","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0072","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1388-1981(02)00324-4","article-title":"Transbilayer phospholipid movement and the clearance of apoptotic cells","volume":"1585","author":"Williamson","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0073","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.cdd.4400404","article-title":"The role of phosphatidylserine in recognition of apoptotic cells by phagocytes","volume":"5","author":"Fadok","year":"1998","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0074","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.181.4.2533","article-title":"ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin","volume":"181","author":"Obeid","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0075","doi-asserted-by":"crossref","first-page":"15239","DOI":"10.1074\/jbc.M208611200","article-title":"Identification of phospholipid scramblase 1 as a novel interacting molecule with beta-secretase (beta -site amyloid precursor protein (APP) cleaving enzyme (BACE)","volume":"278","author":"Kametaka","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0076","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0077","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/febs.13775","article-title":"Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system","volume":"283","author":"Martin","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0078","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0079","doi-asserted-by":"crossref","first-page":"328ra27","DOI":"10.1126\/scitranslmed.aae0105","article-title":"Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma","volume":"8","author":"Garg","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0080","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0081","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003675","article-title":"Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma","volume":"9","author":"Storkus","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0082","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1158\/1078-0432.CCR-19-0709","article-title":"Clinical and antitumor immune responses in relapsed\/refractory follicular lymphoma patients after intranodal injections of IFNalpha-dendritic cells and rituximab: a phase I clinical trial","volume":"25","author":"Cox","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0083","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0084","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2011.04.012","article-title":"Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer","volume":"69","author":"Thara","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0085","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ijc.28766","article-title":"High hydrostatic pressure induces immunogenic cell death in human tumor cells","volume":"135","author":"Fucikova","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcyt.2023.11.014_bib0086","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020594","article-title":"Immunogenic apoptosis as a novel tool for anticancer vaccine development","volume":"19","author":"Montico","year":"2018","journal-title":"Int J Mol Sci"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923011271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923011271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:51:47Z","timestamp":1761443507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923011271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1465324923011271"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.11.014","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell\u2013based vaccine efficiency to elicit antitumor immune response in vitro","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}